In Vitro Sensitivity-Directed Chemotherapy: Clinical Trials

3 trials of In Vitro Sensitivity-Directed Chemotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 31Completed 1

Follow In Vitro Sensitivity-Directed Chemotherapy: new trials by email Literature Review of In Vitro Sensitivity-Directed Chemotherapy trials Research Report on In Vitro Sensitivity-Directed Chemotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
Chemosensitivity Assay, Cytology Specimen Collection Procedure, Gene Expression Analysis - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia
Not applicableCompletedUniversity of Washington342015-09-112022-06-30
Cell Samples From Patients With Leukemia
in vitro sensitivity-directed chemotherapy, cell proliferation assay, fluorescence activated cell sorting - Leukemia
CompletedChildren's Oncology Group102011-07-012016-05-19
Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
carboplatin, cisplatin, cyclophosphamide - Ovarian Cancer
Phase 3CompletedSwiss Cancer Institute3001996-07-012019-05-15

Conditions studied

Carcinoma, Ovarian Epithelial (1)  ·  Leukemia (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myeloid, Chronic-Phase (1)  ·  Leukemia, Promyelocytic, Acute (1)  ·  Ovarian Neoplasms (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Children's Oncology Group (1)  ·  Swiss Cancer Institute (1)  ·  University of Washington (1)

Countries

Switzerland (1)  ·  United States (1)

Top investigators

Jason N. Berman, MD (1)  ·  Mary-Elizabeth Percival (1)  ·  O.R. Kochli, MD (1)

Results publications

PMID 10481771

NIH funding

P30CA015704 (1)